Compounds > vasotocin
Page last updated: 2024-08-22

vasotocin and obe001

vasotocin has been researched along with obe001 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennett, PR; Chollet, A; Fairhurst, AD; Gotteland, JP; Kim, SH; Pohl, O; Terzidou, V1
Ahmed, H; Bennett, PR; Chollet, A; Gotteland, JP; Hanyaloglu, A; Kim, SH; Pohl, O; Riaposova, L; Terzidou, V1

Other Studies

2 other study(ies) available for vasotocin and obe001

ArticleYear
Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor-Mediated Signaling in Human Amnion and Myometrium.
    Molecular pharmacology, 2017, Volume: 91, Issue:4

    Topics: Amnion; Chemokine CCL5; Enzyme Activation; Female; Humans; Inflammation Mediators; Labor, Obstetric; Mitogen-Activated Protein Kinases; Models, Biological; Myometrium; NF-kappa B; Oximes; Pregnancy; Prostaglandins; Pyrrolidines; Receptors, Oxytocin; Signal Transduction; Up-Regulation; Vasotocin

2017
Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F
    Scientific reports, 2019, 04-08, Volume: 9, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Calcium; Cells, Cultured; Cyclooxygenase 2; Dinoprost; Female; Humans; MAP Kinase Signaling System; Muscle Contraction; Myometrium; NF-kappa B; Oximes; Oxytocin; Pregnancy; Pyrrolidines; Tocolytic Agents; Vasotocin

2019